Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
161 - 170 of 892 results
  • Abstract
    Effect of the combination of β-caryophyllene and cannabidiol in a murine model of Dravet syndrome
    Dravet syndrome (DS) is a genetic epileptic encephalopathy usually caused by mutations in the Scn1a gene, which encodes the α1 subunit of the voltage-gated sodium channel NaV1.1. Clinically, patients are affected by multiple types of seizures that begin...
    Nov 11, 2021
  • Abstract
    Involvement of the medial prefrontal cortex in fear memory reconsolidation impairments induced by cannabidiol in rats
    Fear memories can be attenuated by targeting their reconsolidation, which is differentially regulated by medial prefrontal cortex (mPFC) subregions. The major non-psychotomimetic component of the Cannabis plant, cannabidiol (CBD), can disrupt fear memor...
    Nov 11, 2021
  • Abstract
    Brief exposure to delta9 (-) THC affects embryonic and adult locomotion; the effect persisted in the offspring
    The stereoselectivity of a compound plays an essential role in it’s pharmacological activity. δ9 (-) THC is a stereoisomer of THC and is the predominant form present in the cannabis plant, Cannabis sativa. The goal of this study was to determine if brie...
    Nov 9, 2021
  • Abstract
    THC-induced sexually dimorphic alterations in performance on an active place avoidance paradigm
    Marijuana remains the most commonly used illicit drug in the United States, with an estimated 97.5% of Americans age 12 or older having tried the substance at least once in their lifetimes (whitehousedrugpolicy.gov). Additionally, the ontogeny of cannab...
    Nov 7, 2007
  • Abstract
    Identification and characterization of cannabidiol and other cannabinoids as novel agonists of TRPV2
    TRPV2 is a nonselective ligand-gated cation channel considered to be a transducer of high threshold sensory stimuli based on reports of its activation by noxious high heat and membrane stretch. However, further elucidation of its channel properties and ...
    Nov 5, 2007
  • Abstract
    microRNA profiling of human PSP, CBD, and DLBD brain tissues compared to normal controls
    Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD) are sporadic parkinsonian disorders with Tau pathology that share many molecular and clinical features. Patients with these disorders experience relentless neurodegeneration and ty...
    Nov 15, 2016
  • Abstract
    Permanent disruptions of hippocampal GABAergic neurotransmission in adult rats following perinatal ∆9-THC exposure.
    Cannabis or its psychoactive component delta9-tetrahydrocannabinol (∆9-THC) is the most commonly abused illicit drug by pregnant women. Despite its wide use, at present, the long-lasting effects on the adult brain of the offspring are still unclear. It ...
    Nov 12, 2016
  • Abstract
    Inhibitory function and white matter changes in chronic marijuana smokers: a DTI study.
    Abnormalities in executive function and the ability to successfully monitor and inhibit inappropriate behaviors have been reported in substance abusing individuals. Recent investigations which have utilized neuroimaging and neurocognitive techniques to evaluate frontal systems in heavy cannabis smokers have reported alterations during inhibitory tasks which require frontal processing. Diffusion tensor imaging (DTI) methods provide a quantitative estimate of white matter integrity, providing new insight at the microstructural level. We applied diffusion tensor imaging techniques (DTI) and a brief neurocognitive battery which included measures of frontal/executive function to examine the relationship between frontal white matter changes and neuropsychological performance in nine heavy cannabis smokers and 9 matched control subjects. DTI data were acquired on a 3.0 Tesla scanner using a diffusion weighted twice-refocused spin echo EPI sequence. Voxels (11cm3) were placed in the midline of the splenium of the ...
    Nov 16, 2005
  • Abstract
    Modulation of δ9-THC-induced ataxia by mouse cerebellar nicotinic--cholinergic receptor subtype.
    No study regarding effects of Δ9-THC and nicotine co-administration on motor functions is known. Therefore, it was interesting to investigate functional consequences of intracerebellar (ICB) microinfusion of nicotine on ICB Δ9-THC-induced ataxia. Cerebellum was selected because of its established role in Δ9-THC-induced ataxia. Using the Rotorod, the effect of direct ICB microinfusion of various doses of nicotine [5, 2.5,1.25ng] on Δ9-THC [20 µg]-induced ataxia was investigated. There was a significant (p<0.05) attenuation by ICB nicotine on Δ9-THC-induced ataxia in a dose-related manner. The highest nicotine dose (5 ng) virtually abolished the Δ9-THC-induced ataxia. ICB pretreatment with nicotine antagonist hexamethonium (1µg) significantly blocked nicotine’s ability to attenuate Δ9-THC-induced ataxia suggesting that a nicotine - Δ9-THC behavioral interaction involved participation of nAChR. To further elucidate specific subtype of nicotinic receptor involved in the attenuation of Δ9-THC-induced ataxia, di...
    Nov 15, 2005
  • Abstract
    Self-administration of δ-9-tetrahydrocannibinol (THC) in rats: Developing an animal model.
    One of the more valid animal models of abuse potential and addictive liability of drugs is self-administration. Research employing the self-administration paradigm has yielded advancements in our understanding of both general neural reward mechanisms and more specific effects of cocaine, heroin, nicotine, alcohol, and other common drugs of abuse. However, despite the widespread use and abuse of marijuana in the general public for thousands of years, reliable self-administration of the active chemical, Δ-9-tetrahydrocannibinol (THC), has been achieved only recently and only in a single animal species, namely squirrel monkeys. We present the results of two attempts to train Sprague-Dawley rats to self-administer the drug through chronic indwelling jugular catheters. In the first experiment, rats were trained to self-administer cocaine and then tested daily at various doses of THC dissolved in a solution of saline, Tween-80, and ethanol. In the second experiment, rats were trained to lever press for a sucrose...
    Oct 26, 2004
  • Previous
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience